Glaukos Corporation
GKOSNYSEHealthcare● Active
$125.00
+$3.31(+2.72%)
Market Cap$7.3B
P/E Ratio—
52W High$148.11
52W Low$73.16
Glaukos Corporation (GKOS) Earnings: Dates, EPS & Revenue History
Quarterly EPS vs. estimates, revenue surprises, next earnings date, and analyst consensus.
GKOS · earnings · updated Jun 8, 2026
Latest Earnings
Q2 FY2026Report Date: Apr 29, 2026EPS Actual
-$0.18
Est. -$0.30 · +40.0%
Revenue
$0.15B
Est. $0.14B · +9.9%
Fiscal Period
Q2 FY2026
FY ends December
Report Date
Apr 29, 2026
After Market Close
▲ Beat EPS▲ Beat Revenue✓ 1-Quarter EPS Beat Streak
GKOS reports quarterly as a NYSE-listed Medical - Devices company. Fiscal year ends in December. Data: FMP · Updated hourly.
Next Earnings Date
Days Away
85
days
Expected Date
Sep 1, 2026
Fiscal Period
Q3 FY2026
Release Time
◌ Time TBD (Unconfirmed)EPS Est.
$0.37
Rev. $0.36B
Days Away85
Expected DateSep 1, 2026
Fiscal PeriodQ3 FY2026
Release TimeTime TBD (Unconfirmed)
EPS Est.$0.37
Rev. Est.$0.36B
EPS & Revenue vs. Estimates
Actual (Beat)
Actual (Miss)
Estimated
Earnings History
| Period | Report Date | EPS Est. | EPS Actual | EPS Surpr. | Revenue | Rev. Est. | Rev. Surpr. |
|---|---|---|---|---|---|---|---|
| ◌ Q3 FY2026 | Jul 29, 2026 | -$0.21 | — | — | — | $0.15B | — |
| ▲ Q2 FY2026 | Apr 29, 2026 | -$0.30 | -$0.18 | +40.0% | $0.15B | $0.14B | +9.9% |
| ▼ Q1 FY2026 | Feb 17, 2026 | -$0.22 | -$0.28 | -27.3% | $0.14B | $0.14B | +4.9% |
| ▲ Q4 FY2025 | Oct 29, 2025 | -$0.27 | -$0.16 | +40.7% | $0.13B | $0.13B | +3.1% |
| ▲ Q3 FY2025 | Jul 30, 2025 | -$0.26 | -$0.24 | +7.7% | $0.12B | $0.12B | +1.4% |
| ▲ Q2 FY2025 | Apr 30, 2025 | -$0.33 | -$0.22 | +33.3% | $0.11B | $0.10B | +3.8% |
| ▼ Q1 FY2025 | Feb 20, 2025 | -$0.38 | -$0.40 | -5.3% | $0.11B | $0.10B | +4.5% |
| ▲ Q4 FY2024 | Nov 4, 2024 | -$0.52 | -$0.28 | +46.1% | $0.10B | $0.10B | -3.8% |
Q3 FY2026
Jul 29, 2026
EPS Actual
—
EPS Est.
-$0.21
EPS Surpr.
—
Revenue
—
Q2 FY2026
Apr 29, 2026Beat
EPS Actual
-$0.18
EPS Est.
-$0.30
EPS Surpr.
+40.0%
Revenue
$0.15B
Q1 FY2026
Feb 17, 2026Miss
EPS Actual
-$0.28
EPS Est.
-$0.22
EPS Surpr.
-27.3%
Revenue
$0.14B
Q4 FY2025
Oct 29, 2025Beat
EPS Actual
-$0.16
EPS Est.
-$0.27
EPS Surpr.
+40.7%
Revenue
$0.13B
Q3 FY2025
Jul 30, 2025Beat
EPS Actual
-$0.24
EPS Est.
-$0.26
EPS Surpr.
+7.7%
Revenue
$0.12B
Q2 FY2025
Apr 30, 2025Beat
EPS Actual
-$0.22
EPS Est.
-$0.33
EPS Surpr.
+33.3%
Revenue
$0.11B
Q1 FY2025
Feb 20, 2025Miss
EPS Actual
-$0.40
EPS Est.
-$0.38
EPS Surpr.
-5.3%
Revenue
$0.11B
Q4 FY2024
Nov 4, 2024Beat
EPS Actual
-$0.28
EPS Est.
-$0.52
EPS Surpr.
+46.1%
Revenue
$0.10B
Analyst Estimates
EPS Estimates
| Period | Low | Consensus | High | # Analysts |
|---|---|---|---|---|
| Q4 FY2028 | $0.32 | $0.33 | $0.34 | 4 |
| Q3 FY2028 | $0.24 | $0.25 | $0.26 | 6 |
| Q2 FY2028 | $0.13 | $0.13 | $0.14 | 4 |
| Q1 FY2028 | $0.08 | $0.08 | $0.09 | 4 |
| Q4 FY2027 | $0.16 | $0.16 | $0.17 | 3 |
| Q3 FY2027 | $0.11 | $0.12 | $0.12 | 4 |
Revenue Estimates
| Period | Low | Consensus | High | # Analysts |
|---|---|---|---|---|
| Q4 FY2028 | $0.2B | $0.2B | $0.2B | 3 |
| Q3 FY2028 | $0.2B | $0.2B | $0.2B | 5 |
| Q2 FY2028 | $0.2B | $0.2B | $0.2B | 3 |
| Q1 FY2028 | $0.2B | $0.2B | $0.2B | 3 |
| Q4 FY2027 | $0.2B | $0.2B | $0.2B | 4 |
| Q3 FY2027 | $0.2B | $0.2B | $0.2B | 5 |
Earnings Price Reaction
Closing price one trading day before vs. one trading day after each earnings release.
| Period | Report Date | EPS Beat/Miss | Price Before | Price After | 1D Reaction |
|---|---|---|---|---|---|
| ▲ Q2 FY2026 | Apr 29, 2026 | +40.0% | $119.63 | $116.96 | -2.23% |
| ▼ Q1 FY2026 | Feb 17, 2026 | -27.3% | $109.47 | $106.64 | -2.59% |
| ▲ Q4 FY2025 | Oct 29, 2025 | +40.7% | $77.79 | $77.09 | -0.90% |
| ▲ Q3 FY2025 | Jul 30, 2025 | +7.7% | $93.76 | $94.05 | +0.31% |
| ▲ Q2 FY2025 | Apr 30, 2025 | +33.3% | $93.83 | $94.25 | +0.45% |
| ▼ Q1 FY2025 | Feb 20, 2025 | -5.3% | $160.58 | $157.36 | -2.01% |
| ▲ Q4 FY2024 | Nov 4, 2024 | +46.1% | $131.77 | $131.38 | -0.30% |
| ▲ Q3 FY2024 | Jul 31, 2024 | +0.0% | $117.89 | $117.17 | -0.61% |
Q2 FY2026-2.23%
Report Date
Apr 29, 2026
EPS Beat/Miss
+40.0%
Price Before
$119.63
Price After
$116.96
Q1 FY2026-2.59%
Report Date
Feb 17, 2026
EPS Beat/Miss
-27.3%
Price Before
$109.47
Price After
$106.64
Q4 FY2025-0.90%
Report Date
Oct 29, 2025
EPS Beat/Miss
+40.7%
Price Before
$77.79
Price After
$77.09
Q3 FY2025+0.31%
Report Date
Jul 30, 2025
EPS Beat/Miss
+7.7%
Price Before
$93.76
Price After
$94.05
Q2 FY2025+0.45%
Report Date
Apr 30, 2025
EPS Beat/Miss
+33.3%
Price Before
$93.83
Price After
$94.25
Q1 FY2025-2.01%
Report Date
Feb 20, 2025
EPS Beat/Miss
-5.3%
Price Before
$160.58
Price After
$157.36
Q4 FY2024-0.30%
Report Date
Nov 4, 2024
EPS Beat/Miss
+46.1%
Price Before
$131.77
Price After
$131.38
Q3 FY2024-0.61%
Report Date
Jul 31, 2024
EPS Beat/Miss
+0.0%
Price Before
$117.89
Price After
$117.17
Avg Beat Reaction-0.55%
Avg Miss Reaction-2.30%
Beat Rate6 / 8 quarters
Largest Move-2.59% (Q1 FY2026)
Data: FMP /historical-price-eod/full · field: close
About Earnings & Data Methodology
Data source: Financial Modeling Prep (FMP) | Updated: Hourly | Surprise%: (Actual − Estimate) / |Estimate| × 100 | Fiscal year: GKOS ends December
Glaukos Corporation (GKOS) most recently reported earnings on April 29, 2026 for Q2 FY2026, posting EPS of $-0.18 — beating the analyst consensus of $-0.30 by +40.0%. The next GKOS earnings date is expected around September 1, 2026.
Each quarter, investors track GKOS earnings for signals on forward guidance and business momentum. For longer-term revenue trends, see the Revenue tab. GKOS revenue tab →
Earnings Glossary
EPS (Earnings Per Share)
Net income ÷ diluted shares outstanding. The primary metric analysts use to gauge quarterly profitability.
Earnings Surprise %
(Actual − Estimate) / |Estimate| × 100. Positive = Beat. Negative = Miss.
Beat / Miss / In-Line
Beat = Actual ≥ Estimate. Miss = Actual < Estimate. In-Line = within ±1%.
BMO / AMC
Before Market Open / After Market Close. Two windows when companies typically release results.
Fiscal Quarter
GKOS's fiscal year ends in December. Fiscal quarters may not align with calendar quarters.
Analyst Consensus
Average EPS/Revenue forecast across all covering analysts. More analysts = more reliable estimate.
Figures tie to FMP earnings calendar, estimates, and SEC 10-Q/10-K filings where noted.
Frequently asked questions
GKOS earnings · 5 questionsGlaukos Corporation's next earnings report is expected around September 1, 2026. GKOS typically reports quarterly — approximately every three months. The exact date is confirmed by the company 2–4 weeks before the release. Time is currently TBD; GKOS historically reports after market close (AMC).
GKOS earnings datewhen is GKOS earningsGKOS next earnings datewhen does GKOS report earningsGKOS earnings calendar
▸ Source: FMP · Glaukos Corporation SEC filings · US GAAP · Glaukos Corporation SEC 10-K & 10-Q filings · US GAAP · Updated: Jun 8, 2026